Subscribe to MDT Magazine News

Think of the global good

August 17, 2010 10:31 pm | by Mass High Tech: The Journal of New England Technology | Comments

In this issue we set out to address a core question: How do different types of life sciences companies make money? Yet, there's another question that we also felt it was important to address: Can a company work for the public good even when there is little or no hope of turning a profit?


VCs discuss potential life science investment pitfalls

August 17, 2010 9:33 pm | by Mass High Tech: The Journal of New England Technology | Comments

Two Boston VCs known for not being shy of risk, SV Life Sciences' James Garvey and PureTech Ventures' Daphne Zohar, told Mass High Tech where they're applying a higher level of scrutiny before investing and what life science categories they're avoiding like the plague.


Regenerative medicine gets on a profitable roll

August 17, 2010 9:32 pm | by Mass High Tech: The Journal of New England Technology | Comments

After getting off to a false start in the 1990s, the field of regenerative medicine has been reborn over the past decade. Now, several New England companies are showing that regenerative medicine - generally defined as therapy that uses living cells to repair the body - is more than just...


Cardica signs contract deal with Intuitive

August 17, 2010 2:45 pm | by The Associated Press | Comments

Surgical systems maker Cardica Inc. said Tuesday it entered a licensing deal worth $12 million upfront with Intuitive Surgical Inc.Under the deal, Intuitive will get a worldwide, exclusive license to Cardica's intellectual property, which relates to tissue cutting, stapling and clip appliers,...


Cardica 4Q loss narrows on smaller sales force

August 17, 2010 2:45 pm | by The Associated Press | Comments

Surgical systems maker Cardica Inc. said Tuesday its fiscal fourth quarter loss narrowed on lower costs following cuts to its sales force.The company lost $3.1 million, or 13 cents per share, compared with a loss of $3.5 million, or 22 cents per share, during the same period a year prior....

Prospect Medical turns fiscal 3Q profit of $2.8 M

August 17, 2010 12:45 pm | by The Associated Press | Comments

Prospect Medical Holdings Inc., which has agreed to be acquired by a private equity firm, said Tuesday it turned a profit in its fiscal third quarter as revenue edged up 2 percent.The Los Angeles company has five hospitals in Southern California and provides health care management services to...

BridgeHead Software Appoints New EMEA Sales Director to Build on Company & #8217;s Presence in Private and Public Sector European Healthcare

August 17, 2010 9:33 am | by RealWire | Comments

Tony Tomkys comes to BridgeHead Software from CommVault, where he was Business Director for Public SectorAshtead, UK - Tuesday August 17 2010 - BridgeHead Software, the Healthcare Storage Virtualization (HSV) company, today announced the appointment of Tony Tomkys to head up their sales...


BioMarin Initiates Phase 3b Study to Evaluate the Effects of Kuvan on Neurophychiatric Symptoms in Subjects with PKU

August 17, 2010 9:33 am | by Bio-Medicine.Org | Comments

NOVATO, Calif., Aug. 17 /- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that the first subject has initiated treatment in a Phase 3b study (PKU-016) to evaluate the effects of Kuvan (sapropterin dihydrochloride) on neuropsychiatric symptoms in subjects with phenylketonuria...


Advanced Life Sciences to Participate in Key Infectious Disease Conference

August 17, 2010 9:32 am | by Bio-Medicine.Org | Comments

CHICAGO, Aug. 17 /- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS ), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the...


VirtuOx and Watermark Medical Announce Strategic Alliance to Expand Sleep Apnea Home Sleep Testing Solutions

August 17, 2010 9:32 am | by Bio-Medicine.Org | Comments

CORAL SPRINGS, Fla., Aug. 17 /- VirtuOx, Inc., a medical technology services company and industry leader in delivering home sleep testing solutions, today announced an agreement with Watermark Medical, a privately-held, medical products and services company currently servicing the...


Gentiva completes $1B Odyssey HealthCare deal

August 17, 2010 8:45 am | by The Associated Press | Comments

Home health services company Gentiva Health Services Inc. said Tuesday its acquisition of hospice care provider Odyssey HealthCare Inc. has closed.The all-cash deal valued Odyssey at $27 per share and cost about $1 billion including fees and expenses, Gentiva said. Gentiva agreed to buy Odyssey...

TrinityCare Senior Living, Inc. Announces Second Quarter Operating Results

August 17, 2010 2:45 am | by The Associated Press | Comments () —TrinityCare Senior Living, Inc. (OTCBB: TCSR) (the "Company"), which develops, manages and owns faith-based senior living facilities, today announced its operating results for the second quarter of 2010.For the six months ended June 30, 2010, the Company reported...

Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer

August 17, 2010 12:33 am | by Bio-Medicine.Org | Comments

DUBLIN and MYSTIC, Conn., Aug. 17 /- Amarin Corporation plc (Nasdaq: AMRN ), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that Colin W. Stewart has been appointed President, Chief Executive Officer (CEO) and a member of the Company's...


Oridion to Present Results to New Study for the Integrated Pulmonary Index(TM) at ATACCC Conference

August 17, 2010 12:32 am | by Bio-Medicine.Org | Comments

Oridion to Present Results to New Study for the Integrated Pulmonary... -- JERUSALEM and NEEDHAM, Massachusetts, August 17, 2010 /-


Delcath launches stock offering

August 16, 2010 5:45 pm | by The Associated Press | Comments

Medical device maker Delcath Systems Inc. said Monday it has started an offering of about 5.2 million shares to raise funds to pay for clinical trials, research and development and other costs.The offering is expected to close Aug. 20.Delcath has granted the underwriter a 30-day option to buy...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.